Compare Kaltura Inc (KLTR) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kaltura Inc vs Novo Nordisk A/S — how do they compare? Kaltura Inc trades at $1.63 (market cap $249.42M), while Novo Nordisk A/S trades at $45.9 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 833.3× Kaltura Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Kaltura Inc pays none. Which is the better fit depends on your goals.
| KLTR | NVO | |
|---|---|---|
Market Cap | $249.42M | $207.85B |
Sector | Technology | Health |
52-Week High | $1.89 | $63.98 |
52-Week Low | $1.08 | $35.29 |
Enterprise Value | $261.64M | $222.55B |
Dividend Yield | — | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kaltura Inc
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)
Read more on KLTR →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
